Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy

Informacje na temat projektu

IF-EBOla

Identyfikator umowy o grant: 666102

DOI

10.3030/666102

Projekt został zamknięty

Data podpisania przez KE 3 Grudnia 2014

Data rozpoczęcia 1 Listopada 2014

Data zakończenia 31 Października 2017

Finansowanie w ramach

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Koszt całkowity

€ 2 037 770,00

Wkład UE

€ 1 992 770,00

Koordynowany przez

INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT
France

CORDIS oferuje możliwość skorzystania z odnośników do publicznie dostępnych publikacji i rezultatów projektów realizowanych w ramach programów ramowych HORYZONT.

Odnośniki do rezultatów i publikacji związanych z poszczególnymi projektami 7PR, a także odnośniki do niektórych konkretnych kategorii wyników, takich jak zbiory danych i oprogramowanie, są dynamicznie pobierane z systemu OpenAIRE .

Rezultaty

Documents, reports (3)

Ebola virus diversity assessed by sequencing

The report will provide an overview of Ebola virus diversity as assessed by sequencing necessary to optimize the diagnostic, treatment and vaccine approaches.

Whole infectious profiles

The report will provide an overview of the diversity of infectious profiles from available samples.

Ethical regulations, security and safety set up for diagnostic and follow-up of patients of the phase 1 (without treatment)

Ethical regulations set up to work with the present project for diagnostic and treatment

Websites, patent fillings, videos etc. (1)

Creation of the specific website of the project

Creation of the specific website of the project.

Publikacje

Conference proceedings (11)

Metagenomic analyses and genomic fingerprint of co-infections of the EBOLA viral disease

Autorzy: W. Valdivia-, D. Sheoran, G. Dubois, S. Tigrett, F. Veas
Opublikowane w: 2015
Wydawca: Tofo conference on Filovirus, Ebola and Other Filoviruses

Development of a specific polyclonal immunoglobulin against Ebola

Autorzy: C. Herbreteau & IF Ebola
Opublikowane w: 2015
Wydawca: First World Congress on Targeting Ebola

Lessons Learned from the Development of an Ebola Immunotherapy

Autorzy: R Metrop, JF Saluzzo, F Veas, C. Herbreteau
Opublikowane w: 2017
Wydawca: IV International Conference on Mitigation Strategies for Emerging Infectious diseases

Specific polyclonal F(ab’)2immunoglobulin fragments; in vitro characterization and in vivo effectiveness in post-exposure treatment against Zaire Ebola virus in mice

Autorzy: M. Denizot, T. Racine, D. Pannetier, A. Pasquier, H. Raoul, JF Saluzzo, G. Kobinger, F. Veas, C. Herbreteau
Opublikowane w: 2017
Wydawca: The II International Conference CBRNE - Research & Innovation

Atypical immune response of EVD Long-term survivors

Autorzy: Y. Eskira A Sobarzo, F Veas L Lobel
Opublikowane w: 2017
Wydawca: VIII International Conference on Emerging Zoonoses and transboundary Infectious Diseases

The preparedness IF-EBOLA toolbox for rapid and efficient mitigation of upcoming outbreaks. A platform model for emerging diseases

Autorzy: F.Veas
Opublikowane w: 2016
Wydawca: International Conference on Mitigation Strategies for Emerging Infectious diseases

Efficiency of innovative preparedness IF-EBOLA technologies: Ultrasensitive diagnostics, horse anti-Ebola virus polyclonal Fabs & metagenomic analyses of Ebola variants and co-infections

Autorzy: F.Veas
Opublikowane w: 2017
Wydawca: IV International Conference on Mitigation Strategies for Emerging Infectious diseases

Ebola virus Genomic and Metagenomic signature Analyses of the 2014-15 West African Outbreak

Autorzy: W. Valdivia, D. Sheoran, & F. Veas
Opublikowane w: Numer 7th Filovirus Conference, 2015
Wydawca: 7th Filovirus Conference

Multi-technological platforms to solve unmet needs for rapid and efficient management of emerging diseases

Autorzy: F.Veas
Opublikowane w: 2015
Wydawca: XIX International Congress for Tropical Diseases

A Universal virus capture method leading to a rapid and ultrasensitive detection of pathogens for early & late post-exposure countermeasures

Autorzy: S Tigrett, L Lobel, F Veas
Opublikowane w: 2017
Wydawca: VIII International Conference on Emerging Zoonoses and transboundary Infectious diseases

RIGEL as a Powerful Computational Architecture for Genomic & Metagenomic Signature Discrimination: Analysis of the 2014-15 West African EBOLA Outbreak”

Autorzy: W. Valdivia, D. Sheoran & F. Veas
Opublikowane w: Numer Gordon Research Conferences, on Biodefense and Bioterrorism meeting, 2015, Strona(/y) March 8-13, 2015
Wydawca: Gordon Research Conference

Other (1)

Resveratrol-Linoleate protects from exacerbated endothelial permeability via a drastic inhibition of the MMP-9 activity

Autorzy: A Shamseddin, C Crauste, E Durand, P Villeneuve, G Dubois, T Pavlickova, Th Durand, J. Vercauteren, and F Veas
Opublikowane w: 2018
Wydawca: BioScience Reports 2018

Peer reviewed articles (1)

Resveratrol formulated with a natural deep eutectic solvent inhibits active matrix metalloprotease-9 in hormetic conditions

Autorzy: Aly Shamseddin, Céline Crauste, Erwann Durand, Pierre Villeneuve, Gregor Dubois, Thierry Durand, Joseph Vercauteren, Francisco Veas
Opublikowane w: European Journal of Lipid Science and Technology, Numer 119/11, 2017, Strona(/y) 1700171, ISSN 1438-7697
Wydawca: Wiley - V C H Verlag GmbbH & Co.
DOI: 10.1002/ejlt.201700171